Effectiveness of Geriatric Assessment-Driven Interventions on Survival and Functional and Nutritional Status in Older Patients with Head and Neck Cancer: A Randomized Controlled Trial (EGeSOR).
elderly
function
geriatric assessment
head and neck cancer
nutrition
survival
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
05 Jul 2022
05 Jul 2022
Historique:
received:
17
05
2022
revised:
30
06
2022
accepted:
03
07
2022
entrez:
9
7
2022
pubmed:
10
7
2022
medline:
10
7
2022
Statut:
epublish
Résumé
This study assesses the efficacy of Geriatric Assessment (GA)-driven interventions and follow-up on six-month mortality, functional, and nutritional status in older patients with head and neck cancer (HNC). HNC patients aged 65 years or over were included between November 2013 and September 2018 by 15 Ear, Nose, and Throat (ENT) and maxillofacial surgery departments at 13 centers in France. The study was of an open-label, multicenter, randomized, controlled, and parallel-group design, with independent outcome assessments. The patients were randomized 1:1 to benefit from GA-driven interventions and follow-up versus standard of care. The interventions consisted in a pre-therapeutic GA, a standardized geriatric intervention, and follow-up, tailored to the cancer-treatment plan for 24 months. The primary outcome was a composite criterion including six-month mortality, functional impairment (fall in the Activities of Daily Living (ADL) score ≥2), and weight loss ≥10%. Among the patients included (
Identifiants
pubmed: 35805060
pii: cancers14133290
doi: 10.3390/cancers14133290
pmc: PMC9265581
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : the French National Cancer Institute [INCa]
ID : [RAFC1202]
Organisme : Ligue Nationale contre le Cancer
ID : PACAN
Références
Laryngoscope. 2018 Dec;128(12):E416-E424
pubmed: 30329155
BMC Cancer. 2014 Jun 13;14:427
pubmed: 24923533
Eur J Cancer. 2018 Sep;100:65-74
pubmed: 30014882
PLoS One. 2013 Jun 19;8(6):e64834
pubmed: 23840308
J Gerontol A Biol Sci Med Sci. 2015 Sep;70(9):1148-55
pubmed: 25834194
Int J Radiat Oncol Biol Phys. 2011 Jan 1;79(1):46-51
pubmed: 20395066
J Am Geriatr Soc. 1991 Sep;39(9 Pt 2):8S-16S; discussion 17S-18S
pubmed: 1832179
Eur J Cancer Care (Engl). 2020 Jan;29(1):e13170
pubmed: 31571340
Comput Methods Programs Biomed. 2012 Aug;107(2):308-14
pubmed: 22133716
Otolaryngol Clin North Am. 2018 Aug;51(4):741-751
pubmed: 29801920
Eur J Cancer. 1992;28(2-3):426-30
pubmed: 1591057
Eur J Cancer. 2010 Apr;46(6):1019-25
pubmed: 20138506
BMC Cancer. 2016 Dec 1;16(1):932
pubmed: 27908282
J Clin Oncol. 2014 Aug 20;32(24):2595-603
pubmed: 25071125
Oncologist. 2020 Dec;25(12):1032-1038
pubmed: 32820842
BMC Med. 2010 Mar 24;8:18
pubmed: 20334633
Ann Oncol. 2014 Feb;25(2):307-15
pubmed: 24256847
Colorectal Dis. 2018 Jan;20(1):16-25
pubmed: 28649755
BMJ Open. 2018 Mar 16;8(3):e020617
pubmed: 29549210
Cochrane Database Syst Rev. 2017 Sep 12;9:CD006211
pubmed: 28898390
JAMA Netw Open. 2020 Aug 3;3(8):e209265
pubmed: 32822490
JAMA Oncol. 2021 Nov 01;7(11):e214158
pubmed: 34591080
BMJ Open. 2019 May 10;9(5):e024485
pubmed: 31079079
Ann Oncol. 2013 May;24(5):1306-12
pubmed: 23293115
Ann Oncol. 2016 Sep;27(9):1799-804
pubmed: 27358382
J Gerontol A Biol Sci Med Sci. 2005 Jun;60(6):798-803
pubmed: 15983186
Lancet. 2021 Nov 20;398(10314):1894-1904
pubmed: 34741815
BMC Med. 2013 Feb 22;11:48
pubmed: 23433471
Oncologist. 2019 Dec;24(12):e1351-e1359
pubmed: 31324663
Curr Opin Oncol. 2019 May;31(3):121
pubmed: 30985495
Support Care Cancer. 2018 Feb;26(2):605-613
pubmed: 28914366
J Am Geriatr Soc. 2000 Dec;48(12):1707-13
pubmed: 11129765
Br J Cancer. 2021 Jun;124(12):1949-1958
pubmed: 33828260
Oncologist. 2016 Sep;21(9):1091-8
pubmed: 27368883